PI Global Investments
Private Equity

Healthcare Startup VitusCare Raises $3 Mn In Series B Round


For people living with chronic kidney disease, dialysis is a long-term commitment that requires consistent access to specialised care. VitusCare, a dialysis care provider, has secured USD 3 million in a Series B funding participated in by Singapore-based healthcare growth equity firm Liberty Ridge Capital, HDFC Bank, Equentis, NAFA Capital Advisors, existing investors 1Crowd and 3i Partners, and several angel investors.

VitusCare’s expansion is built around a capital-light ‘shop-in-shop’ model that brings specialised dialysis services into existing hospitals. By partnering with hospitals rather than building standalone facilities, the company aims to extend its network while improving operational efficiency. It plans to expand to more than 100 centres by the end of FY27 and is exploring opportunities in select Asian markets.

The fresh capital will support the company’s next phase of growth, including network expansion, technology development and workforce training. VitusCare is also investing heavily in various AI-native business modules to ensure the best possible health care delivery. 

It also plans to establish a Technician Academy to strengthen the pipeline of skilled dialysis professionals as it scales its operations.

Prabhat Shrivastava, Founder and CEO, VitusCare, said, “This fundraise marks an important milestone in VitusCare’s journey. We are focused on building a sustainable dialysis care model that combines clinical excellence with operational efficiency. The confidence our investors have shown in us reinforces our approach to disciplined growth, improving centre-level performance and strengthening our operational foundation. As we expand our network, we remain focused on maintaining consistent care standards while making quality dialysis services more accessible across underserved markets.”

Vasavi Vittal, Founder and Managing Director of Liberty Ridge Capital, a Singapore-based healthcare growth equity firm, added, “VitusCare’s capital-light model offers a differentiated approach to delivering specialised dialysis care through existing hospital infrastructure. Its growth in network reach, revenue and centre-level performance demonstrates the strength of its operating model. We see an opportunity for VitusCare to build on this foundation and expand its presence across India and select international markets.”



Source link

Related posts

AI Agent Infrastructure ‘ALPHEA’ Secures $5 Million in Strategic Funding

D.William

Albert Invent Secures Growth Equity Investment From Applied Ventures to Expand AI Materials R&D Platform

D.William

What’s Going On With Rocket Lab Stock Tuesday? – Rocket Lab (NASDAQ:RKLB)

D.William

Leave a Comment